An estimated 5.17% of patients with inflammatory bowel diseases also have bronchiectasis, as shown in chest CT scans of patients with IBD.

The FDA has expanded the interchangeable designation for Yuflyma (adalimumab-aaty), a biosimilar to Humira, to include all presentations.

Among patients with gastroparesis, cannabis users were more likely than non-users to visit the emergency department or require hospital admission.

AACE released clinical guidelines on the diagnosis, management, and surveillance of tumors related to multiple endocrine neoplasia type 1.

Gut-directed hypnotherapy reduces overall symptom burden and abdominal pain in those with irritable bowel syndrome, according to a recent study.

Exposure to antibiotics following FMT may lead to recurrent CDI, suggesting the need for modified strategies to prevent recurrent CDI in some patients.

Viral and contamination-related foodborne illness outbreaks declined from 2020 to 2022, likely due to food safety measures implemented during the COVID-19 pandemic.

HealthDay News — U.S. Health and Human Services Secretary Robert F. Kennedy Jr. said this week that he may no longer allow government scientists to publish research in top medical journals. Kennedy ...

The US government has canceled a $600 million contract with Moderna to develop a vaccine for bird flu and other dangerous flu strains.

For adults with diabetes and obesity, GLP-1 RAs are associated with a reduced risk for obesity-related cancer compared with DPP-4 inhibitors.

US News & World Report has released its new over-the-counter (OTC) medicine and health product rankings for 2025.

GLP-1 RAs are associated with a significant decrease in apnea-hypopnea index among patients with moderate to severe OSA and without diabetes.